2050 IST, Tuesday, July 22, 2014 
Conversation/Comment
Libya seeks India's help in democratic transition, economic rebuildingBy Gyanendra Kumar Keshri
Libya's new government, formed in 2011 after four decades of Muammar Gaddafi's dictatorial rule, is keen to take India's help in the drafting of a constitution and economic rebuilding, the Libyan envoy here has said. |
'Tagore's concept of humanism more relevant today'
Nobel laureate Rabindranath Tagore's extensive travels around the world, including to China and Iran, left a deep impact on him and his ideals of humanism and a world without barriers is more relevant today, a top official said. |
Zimbabwe beckons Indian drug firmsBy Biswajit Choudhury
Zimbabwe wants Indian firms supplying it generic medicines to produce the drugs locally so that its pharmaceutical sector could grow, the country's helath minister, Henry Madzorera, has said. |
Indian peacekeepers help stabilise South SudanBy Sreeram Sundar Chaulia / The Times of India
The killing of five Indian Army soldiers serving under a UN peacekeeping banner in the recently-created nation state of South Sudan is a poignant reminder of the sacrifices our troops have been rendering for decades to make the world a better place. |
'Made in India' label should inspire confidence in Africa : Zimbabwean envoyBy Biswajit Choudhury
People in the African continent need to be made aware of the changes in India and that "Made in India" products can be of high quality, says a senior African diplomat based in New Delhi. |
Why India's Supreme Court got it right on NovartisBy Achal Prabhala and Kajal Bhardwaj / Business Standard
In September 2007, Arun Kumar*, a serving officer in the Indian Army, was diagnosed with chronic myeloid leukaemia (CML). For the first three of his years of his treatment, he took the standard prescribed dose of the appropriate medicine, imatinib. Then, owing to a sudden spike in the level of chromosomal abnormality that indicates CML, his doctors switched him to a double dose. Today, after six years of treatment, his cancer is under control. The average monthly cost of his imatinib intake is about Rs 20,000 - and this cost, along with every other aspect of his treatment, is borne by the armed forces - from taxpayer funds. An annual bill of Rs 240,000 for medicines for one individual might sound like a lot of money, but Mr Kumar will be lucky if it stays that way. |
'Rwanda's gone from failed state to among Africa's most successful'By Kim Arora / The Times of India
Williams Nkurunziza is Rwanda's high commissioner to India and a poet who's written on Rwanda's genocide. He discussed this violent past, the current standing of President Kagame — and how Rwanda went from genocide to becoming one of the fastest growing nations in the world: |
Quiet diplomacy worked with Italy; PM might still visit Pakistan: Salman KhurshidBy Tarun Basu and Ranjana Narayan
External Affairs Minister Salman Khurshid has said the Indian government's "quiet diplomacy" stood vindicated in the row with Italy and worked in taking a balanced line on Sri Lanka despite pressure to take a far tougher stance. He also maintained that Prime Manmohan Singh might still go to Pakistan if he had a "sense of comfort" that such a visit will result in a "substantive engagement" and "delivery". |
Novartis ruling sifts 'artful' patent from innovationBy Rohit Bansal
India's apex court is in the witness box facing not-so-subtle protests from the $56.67-billion Swiss drugs giant Novartis that is on the losing side of a far-reaching ruling this week on the crucial area of innovation, research and development in life-saving pharmaceuticals. |
Indian firms must grab African opportunity: Guinea-Bissau premierBy Biswajit Choudhury
If Indian companies do not quickly move into West Africa, Western firms will control the 300-million strong market, says Guinea-Bissau Prime Minister Rui Duarte de Barros. |
